EBV based cancer prevention and therapy in nasopharyngeal carcinoma
Abstract Epstein–Barr virus is an important cancer causing virus. Nasopharyngeal carcinoma is an infection-related cancer strongly driven by Epstein–Barr virus. In this cancer model, we identified the major host targets of latent membrane protein 1 which is a driving oncogene encoded by Epstein–Barr...
Guardado en:
Autor principal: | Ya Cao |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Nature Portfolio
2017
|
Materias: | |
Acceso en línea: | https://doaj.org/article/8fadfabaee38471eb4d3e1eb3e25a95b |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
Complete response to PD-1 blockade following EBV-specific T-cell therapy in metastatic nasopharyngeal carcinoma
por: Corey Smith, et al.
Publicado: (2021) -
Cone Beam CT (CBCT) Based Synthetic
CT Generation Using Deep Learning
Methods for Dose Calculation of Nasopharyngeal Carcinoma Radiotherapy
por: Xudong Xue PhD, et al.
Publicado: (2021) -
In vitro human skin permeation of endoxifen: potential for local transdermal therapy for primary prevention and carcinoma in situ of the breast
por: Lee O, et al.
Publicado: (2011) -
Current strategies for the prevention of breast cancer
por: Advani P, et al.
Publicado: (2014) -
A New Tool for CRISPR-Cas13a-BasedCancer Gene Therapy
por: Jinliang Gao, et al.
Publicado: (2021)